Drug Shortage Report for DIMENHYDRINATE INJECTION USP
Report ID | 39961 |
Drug Identification Number | 02435241 |
Brand name | DIMENHYDRINATE INJECTION USP WITH PRESERVATIVE |
Common or Proper name | Dimenhydrinate Injection USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DIMENHYDRINATE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 5 ML |
ATC code | R06AA |
ATC description | ANTIHISTAMINES FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-02-01 |
Estimated end date | 2018-05-10 |
Actual end date | 2018-05-10 |
Shortage status | Resolved |
Updated date | 2018-05-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2018-02-15 | English | Compare |
v1 | 2018-02-15 | English | Compare |